alexa In Vitro Study of Photocurable Embolization Agent for Cerebral Aneurysms | OMICS International | Abstract
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

In Vitro Study of Photocurable Embolization Agent for Cerebral Aneurysms

Ayaka Ishikawa1, Yasuhide Nakayama2* and Nobuaki Kambe1

1Department of Applied Chemistry, Graduate School of Engineering, Osaka University, 2-1 Yamada-oka, Suita 565-0871, Japan

2Division of Medical Engineering and Materials, National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan

Corresponding Author:
Dr. Yasuhide Nakayama
Division of Medical Engineering and Materials
National Cerebral and Cardiovascular Center Research Institute
5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan
Tel: +81-6-6833-5012 (ex.2624)
Fax: +81-6-6872-8090
E-mail: [email protected]

Received date: February 16, 2012; Accepted date: February 23, 2012; Published date: February 25, 2012

Citation: Ishikawa A, Nakayama Y, Kambe N (2012) In Vitro Study of Photocurable Embolization Agent for Cerebral Aneurysms. J Biotechnol Biomaterial 2:128. doi:10.4172/2155-952X.1000128

Copyright: © 2012 Ishikawa A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

The use of liquid embolic agents for the endovascular treatment of cerebral aneurysms has been reported in the neurosurgical literature. A major limitation of these agents is their relatively poor control of hardening ability. In this study, the technical feasibility of a novel gelatin-based photocurable liquid agent for embolization of cerebral aneurysms was evaluated using an experimental aneurysm model. The embolic agent used in this study was an aqueous mixture of photocurable gelatin (gelatin partially derivatized with eosin; 20 wt%; eosin content: 2.8 per gelatin molecule) and polyamine (a polymer of N,N -dimethylaminopropylacrylamide; 5 wt%). Because of its appropriate viscosity at 37 ⁰ C (206 ± 45 mPa•s), the agent could be delivered into the sac of a glass aneurysm model (internal diameter: 3 mm at parent artery part; 5 mm at aneurysm part) by using through a 6 French (Fr)-delivery catheter under the inflation of a balloon catheter at the neck of the aneurysmal sac. After photo irradiation for 40 seconds, the neck of the aneurysm was capped with hydrogel converted from the agent (100%, n=5). Because the colored water was distributed evenly in only a parent tube, complete embolization was observed. Thus, this photocurable agent has potential to be used for the embolization of cerebral aneurysms.

Recommended Conferences

International Conference on Biotechnology and Healthcare

Auckland, New Zealand
Share This Page
Top